Posts tagged Göran Landberg
Sortina Pharma gör exit från SciLifeLab Drug Discovery and Development Platform
Sortina Pharma gör exit från SciLifeLab Drug Discovery and Development Platform

Sortina Pharma, som fokuserar på utveckling av småmolekylära läkemedel som riktar in sig på målproteinet sortilin, ett nyckelprotein med central roll i cancer och neurodegenerativa sjukdomar – har framgångsrikt avslutat sitt samarbete med SciLifeLabs Drug Discovery and Development Platform (DDD). Projektet har fokuserat på att utforska och vidareutveckla sortilins terapeutiska potential, vilket markerar ett viktigt steg framåt i bolagets ambition att erbjuda innovativa behandlingar för sjukdomar med stora medicinska behov.

Read More
NewsMelisha LinnellSortina Pharma, cancer, cancerbehandling, SciLifeLab, SciLifeLab Drug Discovery and Development Platform, Sara Rhost, Göran Landberg
GU Ventures presents its new Board of Directors
GU Ventures presents its new Board of Directors

GU Ventures has been appointed a new Board of Directors at its Annual General Meeting. Four new Board members, were elected, Thomas Andersson, Sophia Litsne, Kristina Torfgård and Per Wassén, and two existing members were re-elected, Göran Landberg and Peter Tellberg. Thomas Andersson was also elected Chair of the Board. All of the board members, through their skills, qualities and experience, will bring further strategic reinforcement, energy and vision for the company's future. Now we start the next leg of our exciting journey into the future!

Read More
PressreleaseMelisha LinnellThomas Andersson, Sophia Litsne, Peter Tellberg, Per Wassén, Kristina Torfgård, Göran Landberg, Board Members, GU Ventures, Anette Asklin, Catharina Bäärnhielm, Anders Hyltander, holdingbolaget vid göteborgs universitet, Innovation, Inkubator, Göteborgs Universitet, Klementina Österberg